Kumar, ShashankPrajapati, Kumari SunitaSingh, Atul KumarKushwaha, Prem PrakashShuaib, MohdGupta, Sanjay2024-01-162024-08-132024-01-162024-08-132021-02-07304383510.1016/j.canlet.2020.11.039https://doi.org/10.1016/j.canlet.2020.11.039http://10.2.3.109/handle/32116/2840The human genome transcribe an array of RNAs that do not encode proteins and may act as mediators in the regulation of gene expression. Long non-coding RNAs (lncRNAs) are a group of non-coding RNAs consisting of more than 200 nucleotides of RNA transcripts that play important role in tumor development. Numerous lncRNAs have been characterized as functional transcripts associated with several biological processes and pathologic stages. Although the biological function and molecular mechanisms of lncRNAs remains to be explored, recent studies demonstrate aberrant expression of several lncRNAs linked with various human cancers. The present review summarizes the current knowledge of lncRNA expression patterns and mechanisms that contribute to carcinogenesis. In particular, we focus on lncRNAs regulating androgen receptor signaling pathways in prostate and breast cancer subtype having prognostic and therapeutic implications. � 2021 Elsevier B.V.en-USAndrogen receptorLong non-coding RNAsProstate cancerSignaling pathwayTriple negative breast cancerShort survey